Join Anna Middleton as she shares real-world strategies on patient engagement through branding, marketing and PR.
Learning objectives:
- Understand the connection between personal purpose and professional brand
- Learn the six pillars of branding and how to apply them
- Be able to define a unique selling proposition and patient messaging
- Gain insight into multi-channel marketing to attract and retain patients
- Know how to implement PR strategies to build reputation and trust
- Feel motivated to join and engage with the GBT Summit 2025.
Book your place for this exciting session to further understand how GBT clinicians can effectively position and grow their personal brand and clinic.
Book a demo
The brand-new GBT machine is the successor to the AIRFLOW Prophylaxis Master. With over 40 years of expertise behind it, the device is optimised for performing high-level guided biofilm therapy (GBT) treatments, providing exceptional comfort for both patients and clinicians while enhancing the efficiency and profitability of the hygiene department. The intuitive interface, automatic handpiece recognition, and an automated GBT mode offer seamless operation, an enhanced workflow, optimised efficiency, and minimally invasive treatment. Thanks to a smart connectivity feature, clinicians stay informed on treatment and device data on their MyEMS dashboard.
Product features
- Intuitive and streamlined interface
- PIEZON NO PAIN MAX module
- Connectivity
- Improved workflow
- Sustainable materials
- Optimized to perform GBT.
Complete the form below to request your demo of the GBT machine with EMS.
Since 1981, Electro Medical Systems has consistently set new standards with its original Swiss-made products. The GBT movement is growing worldwide, with GBT-certified practices leading the way in professional prophylaxis. Supported by top-tier training from the Swiss Dental Academy (SDA), these practices leverage the latest scientific and technological advancements to ensure outstanding patient care and economic success. In a globally unique survey with over 400,000 patients, 94.1% preferred prophylaxis with guided biofilm therapy over conventional methods. A study from the University of Zurich confirms these results.